The results showed that ASWE enhanced NK1R expression on CD4+, CD14+ and CD16+ cells of AD patients by 197, 11.7 and 28.2%, respectively, and on CD14+, CD16+ and CD19+ cells of HC subjects by 52.4, 48.1 and 29.9%, respectively. This evidence concerns the gene CD14 and Alzheimer disease.